Safety of Patients With Hepatitis C Virus Treated With Glecaprevir/Pibrentasvir From Clinical Trials and Real-World Cohorts
mediaposted on 13.05.2021, 08:58 authored by Adis journals on behalf of, Xavier Forns, Jordan J Feld, Douglas E Dylla, Stanislas Pol, Kazuaki Chayama, Jinlin Hou, Jeong Heo, Pietro Lampertico, Ashley Brown, Mark Bondin, Fernando Tatsch, Margaret Burroughs, John Marcinak, Zhenzhen Zhang, Amanda Emmett, Stuart C Gordon, Ira M Jacobson
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.